• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-223 通过靶向 FBXW7 调控上皮-间充质转化促进结直肠癌细胞对阿霉素的耐药性。

MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7.

机构信息

Hubei Province Key Laboratory on Cardiovascular, Cerebrovascular and Metabolic Disorders, Hubei University of Science and Technology, Xianning 437100, China.

Department of Physiology, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning 437100, China.

出版信息

Acta Biochim Biophys Sin (Shanghai). 2018 Jun 1;50(6):597-604. doi: 10.1093/abbs/gmy040.

DOI:10.1093/abbs/gmy040
PMID:29701752
Abstract

Although doxorubicin has become a key drug in cancer treatment, the resistance of colorectal carcinoma to doxorubicin is a major problem in clinical practice. F-box and WD repeat domain-containing 7 (FBXW7) plays important roles in human cancers and is one of the major causes of drug resistance. The miR-223/FBXW7 pathway has been reported to be a crucial clue to the mechanism of chemoresistance in many human cancers, such as gastric cancer, breast cancer, and non-small cell lung cancer. However, it is unclear whether similar mechanisms of doxorubicin resistance are involved in colorectal cancer (CRC). The aim of the current study was to evaluate the role of miR-223/FBXW7 pathway in chemosensitivity in different CRC cell lines and to investigate the relevant underlying mechanisms. We found that high levels of FBXW7 expression were associated with increased doxorubicin sensitivity in different CRC cell lines, and FBXW7 was regulated by miR-223. Overexpression of miR-223 decreased FBXW7 expression and the sensitivity of CRC cells to doxorubicin, while suppression of miR-223 had the opposite effect. Moreover, epithelial-mesenchymal transition (EMT) was proved to be regulated by miR-223/FBXW7 pathway and involved in the drug resistance. In conclusion, miR-223/FBXW7 axis regulates doxorubicin sensitivity through EMT in CRC, which may lead to the development of individualized treatment in clinical practice.

摘要

尽管阿霉素已成为癌症治疗的关键药物,但结直肠癌对阿霉素的耐药性是临床实践中的一个主要问题。F-box 和 WD 重复结构域包含 7 号(FBXW7)在人类癌症中发挥重要作用,是导致耐药性的主要原因之一。miR-223/FBXW7 通路已被报道是许多人类癌症(如胃癌、乳腺癌和非小细胞肺癌)中化疗耐药机制的关键线索。然而,miR-223/FBXW7 通路是否参与结直肠癌(CRC)的耐药机制尚不清楚。本研究旨在评估 miR-223/FBXW7 通路在不同 CRC 细胞系中对化疗敏感性的作用,并探讨相关的潜在机制。我们发现,不同 CRC 细胞系中 FBXW7 表达水平较高与阿霉素敏感性增加相关,而 FBXW7 受 miR-223 调控。miR-223 的过表达降低了 FBXW7 的表达和 CRC 细胞对阿霉素的敏感性,而 miR-223 的抑制则产生相反的效果。此外,上皮-间充质转化(EMT)被证明受 miR-223/FBXW7 通路调控,并参与耐药性。总之,miR-223/FBXW7 轴通过 EMT 调节 CRC 中的阿霉素敏感性,这可能导致临床实践中个体化治疗的发展。

相似文献

1
MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7.miR-223 通过靶向 FBXW7 调控上皮-间充质转化促进结直肠癌细胞对阿霉素的耐药性。
Acta Biochim Biophys Sin (Shanghai). 2018 Jun 1;50(6):597-604. doi: 10.1093/abbs/gmy040.
2
CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.成纤维细胞来源的外泌体通过增强结直肠癌细胞干性和上皮间质转化促进转移和化疗耐药。
Mol Cancer. 2019 May 7;18(1):91. doi: 10.1186/s12943-019-1019-x.
3
Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.长链非编码 RNA CASC2 通过 CASC2/miR-367/FBXW7 轴抑制肝癌细胞的上皮-间充质转化。
Mol Cancer. 2017 Jul 17;16(1):123. doi: 10.1186/s12943-017-0702-z.
4
Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.结直肠癌干细胞通过上调含F-Box/WD重复序列蛋白7并随后降解c-Myc获得化疗耐药性。
Stem Cells. 2017 Sep;35(9):2027-2036. doi: 10.1002/stem.2668. Epub 2017 Jul 31.
5
miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo.miR-92b-3p 通过抑制 FBXW7 在体外和体内促进结直肠癌细胞增殖、侵袭和迁移。
DNA Cell Biol. 2018 May;37(5):501-511. doi: 10.1089/dna.2017.4080. Epub 2018 Mar 9.
6
The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway.胃癌对曲妥珠单抗的敏感性由miR-223/FBXW7通路调控。
Int J Cancer. 2015 Apr 1;136(7):1537-45. doi: 10.1002/ijc.29168. Epub 2014 Sep 11.
7
Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.霍诺酚拮抗 miR-188-5p/FBXW7/c-Myc 通路逆转人乳腺癌多柔比星耐药。
Cancer Chemother Pharmacol. 2021 May;87(5):647-656. doi: 10.1007/s00280-021-04238-w. Epub 2021 Feb 5.
8
MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.微小RNA-223通过靶向F-box蛋白7调控细胞周期促进人胃癌细胞的顺铂耐药性。
J Exp Clin Cancer Res. 2015 Mar 26;34(1):28. doi: 10.1186/s13046-015-0145-6.
9
FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.FAM83D基因敲低通过抑制FBXW7/Notch-1信号通路来调节结直肠癌的增殖、迁移和侵袭。
Biomed Pharmacother. 2017 Jun;90:548-554. doi: 10.1016/j.biopha.2017.03.073. Epub 2017 Apr 11.
10
Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.微小RNA-135b和微小RNA-182的上调通过PI3K/AKT途径靶向ST6GALNAC2促进结直肠癌的化疗耐药性。
Mol Carcinog. 2017 Dec;56(12):2669-2680. doi: 10.1002/mc.22710. Epub 2017 Aug 21.

引用本文的文献

1
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
2
Identifying Molecular Modulators of the Vascular Invasion in Rectal Carcinoma: Role of and Its Co-Dependent Genes.鉴定直肠癌血管侵袭的分子调节因子: 及其共依赖基因的作用。
Int J Mol Sci. 2025 Jun 28;26(13):6261. doi: 10.3390/ijms26136261.
3
Natural compounds as regulators of miRNAs: exploring a new avenue for treating colorectal cancer.
天然化合物作为微小RNA的调节剂:探索治疗结直肠癌的新途径。
Funct Integr Genomics. 2025 Feb 21;25(1):42. doi: 10.1007/s10142-025-01547-8.
4
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces.miR-223-3p 在癌症发生发展和癌症药物耐药中的作用:同一枚硬币,两面不同。
Int J Mol Sci. 2024 Jul 26;25(15):8191. doi: 10.3390/ijms25158191.
5
Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer.HER2阳性胃癌中曲妥珠单抗耐药的机制
Chin J Cancer Res. 2024 Jun 30;36(3):306-321. doi: 10.21147/j.issn.1000-9604.2024.03.07.
6
Molecular insights and clinical implications for the tumor suppressor role of SCF E3 ubiquitin ligase.SCF E3 泛素连接酶的肿瘤抑制作用的分子见解和临床意义。
Biochim Biophys Acta Rev Cancer. 2024 Sep;1879(5):189140. doi: 10.1016/j.bbcan.2024.189140. Epub 2024 Jun 21.
7
MicroRNA‑223 overexpression suppresses protein kinase C ε expression in human leukemia stem cell‑like KG‑1a cells.微小RNA-223过表达抑制人白血病干细胞样KG-1a细胞中蛋白激酶Cε的表达。
Mol Clin Oncol. 2024 May 28;21(1):48. doi: 10.3892/mco.2024.2746. eCollection 2024 Jul.
8
Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.微小 RNA 在结直肠癌中的分子功能:在增殖、血管生成、凋亡和化疗耐药性中的最新作用。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5617-5630. doi: 10.1007/s00210-024-03076-w. Epub 2024 Apr 15.
9
FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies.FBXW7与人类肿瘤:耐药机制及潜在治疗策略
Front Pharmacol. 2023 Nov 13;14:1278056. doi: 10.3389/fphar.2023.1278056. eCollection 2023.
10
miRNAs as short non-coding RNAs in regulating doxorubicin resistance.微小RNA作为短链非编码RNA在调节阿霉素耐药性中的作用
J Cell Commun Signal. 2023 Dec;17(4):1181-1202. doi: 10.1007/s12079-023-00789-0. Epub 2023 Nov 29.